None listed
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
Colgate-Palmolive
Eligibility
Inclusion criteria
Inclusion criteria: Potential subjects must meet ALL of the following criteria: Males and Females, between age 18 - 55, inclusive. Good oral health with no evidence of untreated dental decay or active periodontal disease at the point of sample collection. Subjects will be screened by the dental examiner Willingness to refrain from oral care hygiene for 12 hours prior to sample collection and refrain from eating, drinking (other than water) 4 hrs prior to sample collection. Signed Informed Consent Form.
Exclusion criteria
Exclusion criteria: Potential subjects must NOT HAVE ANY of the following conditions: Hepatitis B or C, HIV infection, oral herpes (cold sore), sinusitis, etc.). Premedication required for dental procedures. Pregnant or breastfeeding. Current or history of infectious disease (i.e. Current contagious illness (i.e. upper respiratory Subject allergic to oral care products or their ingredients. Use of antibiotics any time during or three months prior to entry into the study. Use of therapeutic oral care products within 1 month prior to entry into the study. Abnormal salivary function including medication induced dry mouth Diseases of the soft or hard tissue of the oral cavity Five (5) or more decayed untreated dental sites at screening Active periodontal disease (ie purulent exudate or tooth mobility), or having received periodontal treatment (ex: SRP- scaling and root planing) 6 months before entering study Current smokers or use of tobacco or vaping products Subjects using anticonvulsants, antihistamines, antidepressants, steroids, sedatives, tranquilizers, anti-inflammatory medication or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study Subjects wearing removable retainers, dentures or with fixed orthodontic appliances
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The samples collected will be studied in different phases (genomics and transcriptomics)Timepoint: After Donation in Visit 2 samples will be sent to Genotypic for assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Abhijit Surwade
Colgate-Palmolive India Limited
Outcome results
None listed